Aryl hydrocarbon receptor modulation by tuberculosis drugs impairs host defense and treatment outcomes

Author(s):: Puyskens, A.; Stinn, A.; Vaart, M. van der (0000-0003-0828-7088); Kreuchwig, A.; Protze, J.; Pei, G.; Klemm, M.; Guhlich-Bornhof, U.; Hurwitz, R.; Krishnamoorthy, G.; Schaaf, M.J.M. (0000-0002-5859-8936); Krause, G.; Meijer, A.H. (0000-0002-1325-0725); Kaufmann, S.H.E.; Moura-Alves, P.

Published: 2019
Publication type: Article / Letter to editor

Date issued: 2019-12-31
Language: English
Is part of: Cell Host and Microbe (2019), Vol. 27, no. 2, p. 238-248.e7
hdl: 1887/3134676
doi: 10.1016/j.chom.2019.12.005
URL: https://pubmed.ncbi.nlm.nih.gov/31901518/